Forian Q2 Revenue Jumps 56 Percent
Forian (NASDAQ:FORA) reported second-quarter 2025 results on August 13, 2025, delivering GAAP revenue of $7.5 million, representing 56% year-over-year growth and net income (GAAP) of $224,000. Margin and operating leverage improved following the Kyber Data Science acquisition, with management reaffirming full-year 2025 revenue guidance of $28 million to $30 million. Key areas of strategic focus included large-scale data integrations, robust health economics research demand, and active acquisition pursuits.
Results included $1.9 million in incremental revenue attributable to the October 2024 acquisition of Kyber Data Science, which now operates alongside the organic life sciences data business. Forian’s adjusted EBITDA was $591,000, compared to $78,000 in the prior year period, with cost optimizations also contributing to profitability gains.
-- Max Wygod, Executive Chairman and Chief Executive Officer
Source Fool.com
